Mitomycin and fluorouracil in combination with concomitant radiotherapy: A potentially curable approach for locally advanced head and neck squamous cell carcinoma

Japanese Journal of Clinical Oncology

Volumn 35, Issue 10, 2005, Pages 572-579

  Rastogi, Madhup ^a   Srivastava, Madhu ^a   Chufal, Kundan S ^b   Pant, M C ^a   Srivastava, Kirti ^a   Bhatt, Madanlal B ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b Batra Hospital India   (India)

Author keywords

Concurrent; Head and neck cancer; Hemoglobin; Mitomycin C; Radiotherapy

Indexed keywords

FLUOROURACIL; MITOMYCIN;

ADULT; ADVANCED CANCER; ARTICLE; BEAM THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; DRUG FATALITY; DRUG INFUSION; DRUG TOLERABILITY; DYSPHAGIA; EDEMA; ESOPHAGUS DISEASE; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HEAD AND NECK CARCINOMA; HOARSENESS; HUMAN; LARYNX DISORDER; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NEUTROPENIA; PHARYNX DISEASE; SALIVARY GLAND DISEASE; SKIN MANIFESTATION; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; XEROSTOMIA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; RADIOTHERAPY DOSAGE; SURVIVAL RATE;

EID: 27944478635     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyi155     Document Type: Article

References (38)

1. Kramer S, Gelber RD, Snow JB, Marcial VA, Lowry LD, Davis LW, et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: Final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 1987;10:19-30.
2. Pajak TF, Laramore GE, Marcial VA, Fazekas JT, Cooper J, Rubin P, et al. Elapsed treatment days - a critical item for radiotherapy quality control review in head and neck trials: RTOG report. Int J Radiat Oncol Biol Phys 1991;20:13-20.
3. Tupchong L, Scott CB, Blitzer PH, Marcial VA, Lowry LD, Jacobs JR, et al. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: Long-term follow-up of RTOG study 73-03. Int J Radiat Oncol Biol Phys 1991;20:21-8.
4. Kramer S, Marcial VA, Pajak TF, MacLean CJ, Davis LW. Prognostic factors for loco-regional control and metastasis and the impact on survival. Int J Radiat Oncol Biol Phys 1986;12:573-8.
5. Leibel SA, Scott CB, Mohiuddin M, Marcial VA, Coia LR, Davis LW, et al. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: Results of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys 1991;21:549-56.
6. Rauth AM, Mohindra JK, Tannock IF. Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo. Cancer Res 1983;43:4154-8.
7. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949-55.
8. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-8.
9. Taylor SG, Murthy AK, Griem KL, Recine DC, Kiel K, Blendowski C, et al. Concomitant cisplatin/5-FU infusion and radiotherapy in advanced head and neck cancer: 8-year analysis of results. Head Neck 1997;19:684-91.
10. Adelstein DJ, Lavertu P, Saxton JP, Secic M, Wood BG, Wanamaker JR, et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer 2000;88:876-83.
11. Jeremic B, Shibamoto Y, Milicic B, Nikolic N, Dagovic A, Aleksandrovic J, et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial. J Clin Oncol 2000;18:1458-64.
12. Adelstein DJ, Li Y, Adams GL, Wagner H Jr, Kish JA, Ensley JF, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003;21:92-8.
13. Staar S, Rudat V, Stuetzer H, Dietz A, Volling P, Schroeder M, et al. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy: Results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;50:1161-71.
14. Browman GP, Cripps C, Hodson DI, Eapen L, Sathya J, Levine MN, et al. Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol 1994;12:2648-53.
15. Haffty BG, Son YH, Papac R, Sasaki CT, Weissberg JB, Fischer D, et al. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: Results of the Yale Mitomycin Randomized Trials. J Clin Oncol 1997;15:268-76.
16. Dobrowsky W, Naude J. Continuous hyperfractionated accelerated radiotherapy with/without mitomycin C in head and neck cancers. Radiother Oncol 2000;57:119-24.
17. Budach V, Stuschke M, Budach W, Baumann M, Geismar D, Grabenbauer G, et al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: Final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol 2005;23:1125-35.
18. Christiansen H, Hermann RM, Hille A, Weiss E, Nitsche M, Martin A, et al. Concomitant radiochemotherapy in primary inoperable advanced head and neck cancer with 5-fluorouracil and mitomycin-C. Head Neck 2004; 26:845-53.
19. Abitbol AA, Sridhar KS, Lewin AA, Schwade JG, Raub W Jr, Wolfson A, et al. Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-C (+/- granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma. Cancer 1997;80:266-76.
20. Widder J, Dobrowsky W, Schmid R, Pokrajac B, Selzer E, Potter R. Hyperfractionated accelerated radiochemotherapy (HFA-RCT) with mitomycin C for advanced head and neck cancer. Radiother Oncol 2004;73:173-7.
21. Zakotnik B, Smid L, Budihna M, Lesnicar H, Soba E, Furlan L, et al. Concomitant radiotherapy with mitomycin C and bleomycin compared with radiotherapy alone in inoperable head and neck cancer: Final report. Int J Radiat Oncol Biol Phys 1998;41:1121-7.
22. Weissberg JB, Son YH, Papac RJ, Sasaki C, Fischer DB, Lawrence R, et al. Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. Int J Radiat Oncol Biol Phys 1989;17:3-9.
23. Dinges S, Budach V, Stuschke M, Budach W, Boehmer D, Schrader M, et al. Chemo-radiotherapy for locally advanced head and neck cancer - long term results of a phase II trial. Eur J Cancer 1997;33:1152-5.
24. Pradier O, Eberlein K, Weiss E, Jackel MC, Hess CF. Radiotherapy combined with simultaneous chemotherapy with mitomycin-C and 5-fluorouracil for inoperable head and neck cancer. Br J Radiol 2001;74:368-74.
25. Haffty BG, Wilson LD, Son YH, Cho EI, Papac RJ, Fischer DB, et al. Concurrent chemo-radiotherapy with mitomycin c compared with porfiromycin in squamous cell cancer of the head and neck: Final results of a randomized clinical trial. J Radiat Oncol Biol Phys 2005; 61:119-28.
26. Grau C, Prakash Agarwal J, Jabeen K, Rab Khan A, Abeyakoon S, Hadjieva T, et al. Radiotherapy with or without mitomycin c in the treatment of locally advanced head and neck cancer: Results of the IAEA multicentre randomised trial. Radiother Oncol 2003;67:17-26.
27. Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, Hartz WH, et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1988;14:831-8.
28. Chapman JD. Measurement of tumor hypoxia by invasive and non-invasive procedures: A review of recent clinical studies. Radiother Oncol 1991;20(Suppl 1):13-19.
29. Stadler P, Becker A, Feldmann HJ, Hansgen G, Dunst J, Wurschmidt F, et al. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys 1999;44:749-54.
30. Sartorelli AC. Therapeutic attack of hypoxic cells of solid tumors: presidential address. Cancer Res 1988;48:775-8.
31. Moore JV, Hasleton PS, Buckley CH. Tumour cords in 52 human bronchial and cervical squamous cell carcinomas: Inferences for their cellular kinetics and radiobiology. Br J Cancer 1985;51:407-13.
32. Brown JM. Therapeutic targets in radiotherapy. Int J Radiat Oncol Biol Phys 2001;49:319-26.
33. Brown JM. Tumor microenvironment and the response to anticancer therapy. Cancer Biol Ther 2002;1:453-8.
34. Sartorelli AC, Hodnick WF, Belcourt MF, Tomasz M, Haffty B, Fischer JJ, et al. Mitomycin C: A prototype bioreductive agent. Oncol Res 1994;6: 501-8.
35. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-6.
36. WHO Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland: World Health Organization Offset Publication No. 48; 1979.
37. Thomlinson RH. Reoxygenaation as a function of tumor size and histopathological type. In: Proceedings of the Carmel Conference on Time and Dose Relationship in Radiation Biology as Applied to Radiotherapy. BNL report 50203(C-57) Upton, NY 1969;242-54.
38. Weissberg JB, Son YH, Papac RJ, Sasaki C, Fischer DB, Lawrence R, et al. Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. Int J Radiat Oncol Biol Phys 1989;17:3-9.